News Atlas closes $450m biotech fund, and other financing news Atlas Venture raised $450m for its fourteenth biotech round, while Nuvig, Maze, and Antag also closed financings this week.
News Andexxa reaches the end of the line in the US AstraZeneca will voluntarily take its anticoagulant reversal agent Andexxa off the market in the US amid reports of serious clotting side effects.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
